“…The diversification of imaging modalities, such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), photoacoustic imaging (PI), positron emission tomography (PET) and fluorescence imaging (FI) has facilitated early diagnoses and targeted therapies. Compared to other well-developed techniques, FI with small-molecule dyes, in the near infrared region (NIR, 700–1000 nm), has been widely applied for real-time detection of biological species and identification of cancer cells or lymph nodes, as well as for the intraoperative image-guided surgical removal of pathological tissues, owing to its high sensitivity, excellent resolution, minimum photodamage to tissues, quick feedback, non-hazardous radiation and, last, but not least, its low costs and sustainability [ 1 , 2 , 3 ]. Most of the traditional fluorescent probes, such as rhodamine, cyanine, or coumarin derivatives, have absorption and emission in the UV-Vis range and the interference with haemoglobin, myoglobin, and other haemoproteins leads to light scattering and impaired tissue penetration.…”